Functional impairment of sinusoidal membrane transport of organic cations in rats with CCI4-induced hepatic failure

被引:11
作者
Hong, SS [1 ]
Chung, SJ [1 ]
Shim, CK [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Dept Pharmaceut, Seoul 151742, South Korea
关键词
CCl4; organic cations (OCs); hepatocytes; uptake; efflux; excretion;
D O I
10.1023/A:1007508325512
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The effect of CCl4-induced experimental hepatic failure (EHF) on the sequential hepatobiliary transport of model organic cations (OCs), triethylmethylammonium (TEMA), and tributylmethylammonium (TBuMA), was investigated in rats. Methods. EHF was induced by an i.p. injection of CCl4 at a dose of 1 ml/kg 24 hr prior to the transport study. The cumulative in vivo biliary excretion, in vitro hepatic uptake by isolated hepatocytes, in vitro efflux (i.e., release) from hepatocytes, and in vivo hepatobiliary excretion clearance were measured for normal and CCl4-EHF rats. Results. The CCl4-EHF decreased the apparent in vivo biliary clearance (CLb) and the in vitro maximum uptake rate (V-max, up(take)) of TBuMA by 66 and 48%, respectively. The CCl4-EHF had no effect on the CLb of TEMA, but decreased both the V-max, (uptake) (59%) and the in vitro maximum hepatic efflux rate (V-max, (efflux)) of TEMA (80%). On the contrary, the CCl4-EHF had no influence on the in vivo hepatobiliary excretion clearance (CLexc) of both OCs. Conclusions. Transport systems for the OCs on the sinusoidal membrane (uptake and/or efflux), rather than those on the bile canalicular membrane (excretion) appear to be prone to damage by the CCl4-EHF.
引用
收藏
页码:833 / 838
页数:6
相关论文
共 13 条
[1]   EFFECTS OF CARBON-TETRACHLORIDE AND CHLOROFORM ON BILE-ACID TRANSPORT IN ISOLATED RAT HEPATOCYTES - RELATIONSHIP TO ELEVATED SERUM BILE-ACIDS [J].
BAI, CL ;
STACEY, NH .
TOXICOLOGY IN VITRO, 1993, 7 (03) :197-203
[2]   NEW CONCEPTS OF MECHANISMS OF HEPATOCYTE BILE FORMATION [J].
BOYER, JL .
PHYSIOLOGICAL REVIEWS, 1980, 60 (02) :303-326
[3]  
Han YH, 1999, DRUG METAB DISPOS, V27, P872
[4]  
KIMURA T, 1993, BIOL PHARM BULL, V16, P1140
[5]  
KLAASSEN C D, 1968, Toxicology and Applied Pharmacology, V12, P132, DOI 10.1016/0041-008X(68)90182-8
[6]   Organic cation transporters in intestine, kidney, liver, and brain [J].
Koepsell, H .
ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 :243-266
[7]   Hepatobiliary elimination of cationic drugs: The role of P-glycoproteins and other ATP-dependent transporters [J].
Meijer, DKF ;
Smit, JW ;
Muller, M .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 25 (2-3) :159-200
[8]  
NAKATSUKASA H, 1993, HEPATOLOGY, V18, P1202
[9]  
NEEF C, 1984, Biochemical Pharmacology, V33, P3977, DOI 10.1016/0006-2952(84)90011-X
[10]   STRUCTURE-PHARMACOKINETICS RELATIONSHIP OF QUATERNARY AMMONIUM-COMPOUNDS - ELIMINATION AND DISTRIBUTION CHARACTERISTICS [J].
NEEF, C ;
OOSTING, R ;
MEIJER, DKF .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 328 (02) :103-110